 Christina Chambers
Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Alcohol Spectrum Disorders | 4 | 2016 | 26 | 0.920 |
Why?
| | Drug Hypersensitivity | 1 | 2023 | 85 | 0.860 |
Why?
| | Hypersensitivity | 1 | 2023 | 270 | 0.730 |
Why?
| | Breast Feeding | 2 | 2018 | 381 | 0.660 |
Why?
| | Milk, Human | 1 | 2018 | 134 | 0.590 |
Why?
| | Cannabinoids | 1 | 2018 | 115 | 0.580 |
Why?
| | Marijuana Use | 1 | 2018 | 157 | 0.530 |
Why?
| | Craniofacial Abnormalities | 1 | 2009 | 59 | 0.340 |
Why?
| | Frontal Lobe | 1 | 2009 | 147 | 0.320 |
Why?
| | Physical Examination | 2 | 2016 | 242 | 0.290 |
Why?
| | Infant | 9 | 2023 | 8254 | 0.280 |
Why?
| | C-Peptide | 2 | 2018 | 139 | 0.270 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2019 | 465 | 0.270 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2018 | 2159 | 0.260 |
Why?
| | Penicillins | 1 | 2023 | 52 | 0.240 |
Why?
| | Alcohol Drinking | 3 | 2019 | 651 | 0.230 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 10 | 0.210 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 18 | 0.210 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2021 | 29 | 0.190 |
Why?
| | Adrenal Insufficiency | 1 | 2021 | 30 | 0.190 |
Why?
| | Pediatrics | 2 | 2016 | 980 | 0.190 |
Why?
| | Heart Defects, Congenital | 2 | 2017 | 700 | 0.180 |
Why?
| | Weight Gain | 2 | 2022 | 485 | 0.180 |
Why?
| | Family | 1 | 2023 | 578 | 0.180 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 1999 | 37 | 0.180 |
Why?
| | Clinical Competence | 1 | 2006 | 950 | 0.180 |
Why?
| | Fluoxetine | 1 | 1999 | 47 | 0.170 |
Why?
| | Infant, Newborn | 6 | 2020 | 5230 | 0.170 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 106 | 0.170 |
Why?
| | Antidepressive Agents | 1 | 2020 | 189 | 0.160 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 63 | 0.160 |
Why?
| | Overweight | 2 | 2022 | 492 | 0.150 |
Why?
| | Public Health Surveillance | 1 | 2017 | 57 | 0.150 |
Why?
| | Adolescent | 9 | 2022 | 18364 | 0.150 |
Why?
| | Pregnancy Trimester, Second | 1 | 2016 | 70 | 0.140 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 91 | 0.140 |
Why?
| | Pregnancy Trimester, First | 1 | 2016 | 126 | 0.140 |
Why?
| | Pregnancy | 6 | 2020 | 5671 | 0.140 |
Why?
| | Female | 14 | 2022 | 61261 | 0.140 |
Why?
| | C-Reactive Protein | 1 | 2018 | 364 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2020 | 447 | 0.130 |
Why?
| | Male | 13 | 2022 | 57474 | 0.130 |
Why?
| | Retrospective Studies | 5 | 2023 | 12929 | 0.130 |
Why?
| | Child | 8 | 2022 | 19033 | 0.130 |
Why?
| | Humans | 17 | 2023 | 118251 | 0.130 |
Why?
| | Gestational Age | 1 | 2017 | 765 | 0.130 |
Why?
| | Child Development | 1 | 2019 | 402 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1514 | 0.120 |
Why?
| | Anxiety | 1 | 2020 | 845 | 0.120 |
Why?
| | Body Mass Index | 2 | 2022 | 2074 | 0.120 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1019 | 0.120 |
Why?
| | Mothers | 1 | 2018 | 675 | 0.110 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1787 | 0.110 |
Why?
| | Depression | 1 | 2020 | 1133 | 0.100 |
Why?
| | California | 3 | 2017 | 370 | 0.100 |
Why?
| | Hypoglycemia | 1 | 2016 | 401 | 0.100 |
Why?
| | Child, Preschool | 5 | 2017 | 9448 | 0.100 |
Why?
| | Young Adult | 6 | 2020 | 10731 | 0.100 |
Why?
| | Electronic Health Records | 1 | 2017 | 809 | 0.090 |
Why?
| | Autoantibodies | 1 | 2018 | 1334 | 0.090 |
Why?
| | MicroRNAs | 1 | 2016 | 633 | 0.090 |
Why?
| | Cephalometry | 1 | 2009 | 28 | 0.090 |
Why?
| | Microcephaly | 1 | 2009 | 54 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2016 | 1031 | 0.080 |
Why?
| | Quality Improvement | 1 | 2016 | 962 | 0.080 |
Why?
| | Adult | 6 | 2020 | 31324 | 0.080 |
Why?
| | Ukraine | 2 | 2019 | 10 | 0.080 |
Why?
| | Hospitalization | 1 | 2016 | 1778 | 0.070 |
Why?
| | Insulin | 1 | 2016 | 2157 | 0.070 |
Why?
| | Colorado | 1 | 2015 | 4178 | 0.070 |
Why?
| | Mutation | 1 | 2015 | 3435 | 0.060 |
Why?
| | Cohort Studies | 3 | 2017 | 5078 | 0.060 |
Why?
| | Biomarkers | 3 | 2018 | 3567 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2006 | 2855 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2021 | 303 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2659 | 0.040 |
Why?
| | Linear Models | 1 | 1999 | 817 | 0.040 |
Why?
| | Forecasting | 1 | 2019 | 348 | 0.040 |
Why?
| | Obesity | 2 | 2022 | 2715 | 0.040 |
Why?
| | Perinatal Care | 1 | 2016 | 37 | 0.040 |
Why?
| | Risk Factors | 2 | 2022 | 8958 | 0.030 |
Why?
| | Maternal Behavior | 1 | 2016 | 64 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2006 | 4521 | 0.030 |
Why?
| | Developmental Disabilities | 1 | 2019 | 245 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 119 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 463 | 0.030 |
Why?
| | Genetic Testing | 1 | 2018 | 388 | 0.030 |
Why?
| | Prenatal Diagnosis | 1 | 2016 | 167 | 0.030 |
Why?
| | Physician's Role | 1 | 2016 | 200 | 0.030 |
Why?
| | Algorithms | 1 | 2022 | 1522 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 980 | 0.030 |
Why?
| | Risk | 1 | 2016 | 849 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 479 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 993 | 0.030 |
Why?
| | Comorbidity | 1 | 2017 | 1516 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 504 | 0.030 |
Why?
| | Databases, Factual | 1 | 2017 | 1196 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1896 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1379 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2491 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1857 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1027 | 0.030 |
Why?
| | Incidence | 1 | 2017 | 2413 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3043 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2990 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3156 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4574 | 0.020 |
Why?
| | Registries | 1 | 2017 | 1806 | 0.020 |
Why?
| | Vaccination | 1 | 2017 | 1218 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3424 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1433 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6443 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6541 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2016 | 9319 | 0.010 |
Why?
| | Aged | 1 | 2017 | 19594 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 27510 | 0.010 |
Why?
| | Animals | 1 | 2016 | 33152 | 0.010 |
Why?
|
|
Chambers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|